Global Mesalazine Market Growth 2020-2025

Publisher Name :
Date: 27-Aug-2020
No. of pages: 165

According to this study, over the next five years the Mesalazine market will register a 4.3%% CAGR in terms of revenue, the global market size will reach $ 155.8 million by 2025, from $ 131.7 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Mesalazine business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Mesalazine market by product type, application, key manufacturers and key regions and countries.

This study specially analyses the impact of Covid-19 outbreak on the Mesalazine, covering the supply chain analysis, impact assessment to the Mesalazine market size growth rate in several scenarios, and the measures to be undertaken by Mesalazine companies in response to the COVID-19 epidemic.

Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.

- Purity = 97 %

- Purity = 98 %

- Purity = 99 %

- According to the type, purity = 98% is the highest, reaching 48.44% in 2019.

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.

- Mesalazine Tablets

- Mesalazine Capsules

- Others

- Mesalazine tablets has the highest market share in terms of application, at 50.61% in 2019.

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

- Americas

- United States

- Canada

- Mexico

- Brazil

- APAC

- China

- Japan

- Korea

- Southeast Asia

- India

- Australia

- Europe

- Germany

- France

- UK

- Italy

- Russia

- Middle East & Africa

- Egypt

- South Africa

- Israel

- Turkey

- GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.

- Syntese A/S

- Ishita Active Pharma Ingredients

- Divis Laboratories

- Ipca Laboratories

- PharmaZell

- Cambrex Corporation

- Corden Pharma Bergamo

- Lasa Loboratory

- CTX Lifescience

- Erregierre SpA

- YC Biotech (Jiangsu)

- Xinxiang Tianfeng Fine Chemical

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

- To study and analyze the global Mesalazine consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.

- To understand the structure of Mesalazine market by identifying its various subsegments.

- Focuses on the key global Mesalazine manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

- To analyze the Mesalazine with respect to individual growth trends, future prospects, and their contribution to the total market.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- To project the consumption of Mesalazine submarkets, with respect to key regions (along with their respective key countries).

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

- To strategically profile the key players and comprehensively analyze their growth strategies.

Global Mesalazine Market Growth 2020-2025

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Mesalazine Consumption 2015-2025
2.1.2 Mesalazine Consumption CAGR by Region
2.2 Mesalazine Segment by Type
2.2.1 Purity = 97 %
2.2.2 Purity = 98 %
2.2.3 Purity = 99 %
2.3 Mesalazine Consumption by Type
2.3.1 Global Mesalazine Consumption Market Share by Type (2015-2020)
2.3.2 Global Mesalazine Revenue and Market Share by Type (2015-2020)
2.3.3 Global Mesalazine Sale Price by Type (2015-2020)
2.4 Mesalazine Segment by Application
2.4.1 Mesalazine Tablets
2.4.2 Mesalazine Capsules
2.4.3 Others
2.5 Mesalazine Consumption by Application
2.5.1 Global Mesalazine Consumption Market Share by Type (2015-2020)
2.5.2 Global Mesalazine Value and Market Share by Type (2015-2020)
2.5.3 Global Mesalazine Sale Price by Type (2015-2020)

3 Global Mesalazine by Company
3.1 Global Mesalazine Sales Market Share by Company
3.1.1 Global Mesalazine Sales by Company (2018-2020)
3.1.2 Global Mesalazine Sales Market Share by Company (2018-2020)
3.2 Global Mesalazine Revenue Market Share by Company
3.2.1 Global Mesalazine Revenue by Company (2018-2020)
3.2.2 Global Mesalazine Revenue Market Share by Company (2018-2020)
3.3 Global Mesalazine Sale Price by Company
3.4 Global Mesalazine Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Mesalazine Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Mesalazine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Mesalazine by Regions
4.1 Mesalazine by Regions
4.2 Americas Mesalazine Consumption Growth
4.3 APAC Mesalazine Consumption Growth
4.4 Europe Mesalazine Consumption Growth
4.5 Middle East & Africa Mesalazine Consumption Growth

5 Americas
5.1 Americas Mesalazine Consumption by Countries
5.1.1 Americas Mesalazine Consumption by Countries (2015-2020)
5.1.2 Americas Mesalazine Value by Countries (2015-2020)
5.2 Americas Mesalazine Consumption by Type
5.3 Americas Mesalazine Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Mesalazine Consumption by Regions
6.1.1 APAC Mesalazine Consumption by Regions (2015-2020)
6.1.2 APAC Mesalazine Value by Regions (2015-2020)
6.2 APAC Mesalazine Consumption by Type
6.3 APAC Mesalazine Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions

7 Europe
7.1 Europe Mesalazine by Countries
7.1.1 Europe Mesalazine Consumption by Countries (2015-2020)
7.1.2 Europe Mesalazine Value by Countries (2015-2020)
7.2 Europe Mesalazine Consumption by Type
7.3 Europe Mesalazine Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Mesalazine by Countries
8.1.1 Middle East & Africa Mesalazine Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Mesalazine Value by Countries (2015-2020)
8.2 Middle East & Africa Mesalazine Consumption by Type
8.3 Middle East & Africa Mesalazine Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Mesalazine Distributors
10.3 Mesalazine Customer

11 Global Mesalazine Market Forecast
11.1 Global Mesalazine Consumption Forecast (2021-2025)
11.2 Global Mesalazine Forecast by Regions
11.2.1 Global Mesalazine Forecast by Regions (2021-2025)
11.2.2 Global Mesalazine Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Mesalazine Forecast by Type
11.8 Global Mesalazine Forecast by Application

12 Key Players Analysis
12.1 Syntese A/S
12.1.1 Company Information
12.1.2 Mesalazine Product Offered
12.1.3 Syntese A/S Mesalazine Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Syntese A/S Latest Developments
12.2 Ishita Active Pharma Ingredients
12.2.1 Company Information
12.2.2 Mesalazine Product Offered
12.2.3 Ishita Active Pharma Ingredients Mesalazine Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Ishita Active Pharma Ingredients Latest Developments
12.3 Divis Laboratories
12.3.1 Company Information
12.3.2 Mesalazine Product Offered
12.3.3 Divis Laboratories Mesalazine Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Divis Laboratories Latest Developments
12.4 Ipca Laboratories
12.4.1 Company Information
12.4.2 Mesalazine Product Offered
12.4.3 Ipca Laboratories Mesalazine Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Ipca Laboratories Latest Developments
12.5 PharmaZell
12.5.1 Company Information
12.5.2 Mesalazine Product Offered
12.5.3 PharmaZell Mesalazine Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 PharmaZell Latest Developments
12.6 Cambrex Corporation
12.6.1 Company Information
12.6.2 Mesalazine Product Offered
12.6.3 Cambrex Corporation Mesalazine Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Cambrex Corporation Latest Developments
12.7 Corden Pharma Bergamo
12.7.1 Company Information
12.7.2 Mesalazine Product Offered
12.7.3 Corden Pharma Bergamo Mesalazine Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Corden Pharma Bergamo Latest Developments
12.8 Lasa Loboratory
12.8.1 Company Information
12.8.2 Mesalazine Product Offered
12.8.3 Lasa Loboratory Mesalazine Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Lasa Loboratory Latest Developments
12.9 CTX Lifescience
12.9.1 Company Information
12.9.2 Mesalazine Product Offered
12.9.3 CTX Lifescience Mesalazine Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 CTX Lifescience Latest Developments
12.10 Erregierre SpA
12.10.1 Company Information
12.10.2 Mesalazine Product Offered
12.10.3 Erregierre SpA Mesalazine Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Erregierre SpA Latest Developments
12.11 YC Biotech (Jiangsu)
12.11.1 Company Information
12.11.2 Mesalazine Product Offered
12.11.3 YC Biotech (Jiangsu) Mesalazine Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 YC Biotech (Jiangsu) Latest Developments
12.12 Xinxiang Tianfeng Fine Chemical
12.12.1 Company Information
12.12.2 Mesalazine Product Offered
12.12.3 Xinxiang Tianfeng Fine Chemical Mesalazine Sales, Revenue, Price and Gross Margin (2018-2020)
12.12.4 Main Business Overview
12.12.5 Xinxiang Tianfeng Fine Chemical Latest Developments

13 Research Findings and Conclusion

List of Tables

Table 1. Research Methodology
Table 2. Data Source
Table 3. Mesalazine Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Purity = 97 %
Table 5. Major Players of Purity = 98 %
Table 6. Major Players of Purity = 99 %
Table 7. Global Consumption Sales by Type (2015-2020)
Table 8. Global Mesalazine Consumption Market Share by Type (2015-2020)
Table 9. Global Mesalazine Revenue by Type (2015-2020) ($ million)
Table 10. Global Mesalazine Value Market Share by Type (2015-2020) ($ Millions)
Table 11. Global Mesalazine Sale Price by Type (2015-2020)
Table 12. Global Consumption Sales by Application (2015-2020)
Table 13. Global Mesalazine Consumption Market Share by Application (2015-2020)
Table 14. Global Mesalazine Value by Application (2015-2020)
Table 15. Global Mesalazine Value Market Share by Application (2015-2020)
Table 16. Global Mesalazine Sale Price by Application (2015-2020)
Table 17. Global Mesalazine Sales by Company (2017-2019) (Ton)
Table 18. Global Mesalazine Sales Market Share by Company (2017-2019)
Table 19. Global Mesalazine Revenue by Company (2017-2019) ($ Millions)
Table 20. Global Mesalazine Revenue Market Share by Company (2017-2019)
Table 21. Global Mesalazine Sale Price by Company (2017-2019)
Table 22. Global Mesalazine Manufacturing Base Distribution and Sales Area by Manufacturers
Table 23. Players Mesalazine Products Offered
Table 24. Mesalazine Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 25. Global Mesalazine Consumption by Regions 2015-2020 (Ton)
Table 26. Global Mesalazine Consumption Market Share by Regions 2015-2020
Table 27. Global Mesalazine Value by Regions 2015-2020 ($ Millions)
Table 28. Global Mesalazine Value Market Share by Regions 2015-2020
Table 29. Americas Mesalazine Consumption by Countries (2015-2020) (Ton)
Table 30. Americas Mesalazine Consumption Market Share by Countries (2015-2020)
Table 31. Americas Mesalazine Value by Countries (2015-2020) ($ Millions)
Table 32. Americas Mesalazine Value Market Share by Countries (2015-2020)
Table 33. Americas Mesalazine Consumption by Type (2015-2020) (Ton)
Table 34. Americas Mesalazine Consumption Market Share by Type (2015-2020)
Table 35. Americas Mesalazine Consumption by Application (2015-2020) (Ton)
Table 36. Americas Mesalazine Consumption Market Share by Application (2015-2020)
Table 37. APAC Mesalazine Consumption by Countries (2015-2020) (Ton)
Table 38. APAC Mesalazine Consumption Market Share by Countries (2015-2020)
Table 39. APAC Mesalazine Value by Regions (2015-2020) ($ Millions)
Table 40. APAC Mesalazine Value Market Share by Regions (2015-2020)
Table 41. APAC Mesalazine Consumption by Type (2015-2020) (Ton)
Table 42. APAC Mesalazine Consumption Market Share by Type (2015-2020)
Table 43. APAC Mesalazine Consumption by Application (2015-2020) (Ton)
Table 44. APAC Mesalazine Consumption Market Share by Application (2015-2020)
Table 45. Europe Mesalazine Consumption by Countries (2015-2020) (Ton)
Table 46. Europe Mesalazine Consumption Market Share by Countries (2015-2020)
Table 47. Europe Mesalazine Value by Countries (2015-2020) ($ Millions)
Table 48. Europe Mesalazine Value Market Share by Countries (2015-2020)
Table 49. Europe Mesalazine Consumption by Type (2015-2020) (Ton)
Table 50. Europe Mesalazine Consumption Market Share by Type (2015-2020)
Table 51. Europe Mesalazine Consumption by Application (2015-2020) (Ton)
Table 52. Europe Mesalazine Consumption Market Share by Application (2015-2020)
Table 53. Middle East & Africa Mesalazine Consumption by Countries (2015-2020) (Ton)
Table 54. Middle East & Africa Mesalazine Consumption Market Share by Countries (2015-2020)
Table 55. Middle East & Africa Mesalazine Value by Countries (2015-2020) ($ Millions)
Table 56. Middle East & Africa Mesalazine Value Market Share by Countries (2015-2020)
Table 57. Middle East & Africa Mesalazine Consumption by Type (2015-2020) (Ton)
Table 58. Middle East & Africa Mesalazine Consumption Market Share by Type (2015-2020)
Table 59. Middle East & Africa Mesalazine Consumption by Application (2015-2020) (Ton)
Table 60. Middle East & Africa Mesalazine Consumption Market Share by Application (2015-2020)
Table 61. Mesalazine Distributors List
Table 62. Mesalazine Customer List
Table 63. Global Mesalazine Consumption Forecast by Countries (2021-2025) (Ton)
Table 64. Global Mesalazine Consumption Market Forecast by Regions
Table 65. Global Mesalazine Value Forecast by Countries (2021-2025) ($ Millions)
Table 66. Global Mesalazine Value Market Share Forecast by Regions
Table 67. Global Mesalazine Consumption Forecast by Type (2021-2025) (Ton)
Table 68. Global Mesalazine Consumption Market Share Forecast by Type (2021-2025)
Table 69. Global Mesalazine Value Forecast by Type (2021-2025) ($ Millions)
Table 70. Global Mesalazine Value Market Share Forecast by Type (2021-2025)
Table 71. Global Mesalazine Consumption Forecast by Application (2021-2025) (Ton)
Table 72. Global Mesalazine Consumption Market Share Forecast by Application (2021-2025)
Table 73. Global Mesalazine Value Forecast by Application (2021-2025) ($ Millions)
Table 74. Global Mesalazine Value Market Share Forecast by Application (2021-2025)
Table 75. Syntese A/S Product Offered
Table 76. Syntese A/S Mesalazine Sales (Ton), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2020E)
Table 77. Syntese A/S Main Business
Table 78. Syntese A/S Latest Developments
Table 79. Syntese A/S Basic Information, Company Total Revenue (in $ million), Mesalazine Manufacturing Base, Sales Area and Its Competitors
Table 80. Ishita Active Pharma Ingredients Product Offered
Table 81. Ishita Active Pharma Ingredients Mesalazine Sales (Ton), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2020E)
Table 82. Ishita Active Pharma Ingredients Main Business
Table 83. Ishita Active Pharma Ingredients Latest Developments
Table 84. Ishita Active Pharma Ingredients Basic Information, Company Total Revenue (in $ million), Mesalazine Manufacturing Base, Sales Area and Its Competitors
Table 85. Divis Laboratories Product Offered
Table 86. Divis Laboratories Mesalazine Sales (Ton), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2020E)
Table 87. Divis Laboratories Main Business
Table 88. Divis Laboratories Latest Developments
Table 89. Divis Laboratories Basic Information, Company Total Revenue (in $ million), Mesalazine Manufacturing Base, Sales Area and Its Competitors
Table 90. Ipca Laboratories Product Offered
Table 91. Ipca Laboratories Mesalazine Sales (Ton), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2020E)
Table 92. Ipca Laboratories Main Business
Table 93. Ipca Laboratories Latest Developments
Table 94. Ipca Laboratories Basic Information, Company Total Revenue (in $ million), Mesalazine Manufacturing Base, Sales Area and Its Competitors
Table 95. PharmaZell Product Offered
Table 96. PharmaZell Mesalazine Sales (Ton), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2020E)
Table 97. PharmaZell Main Business
Table 98. PharmaZell Latest Developments
Table 99. PharmaZell Basic Information, Company Total Revenue (in $ million), Mesalazine Manufacturing Base, Sales Area and Its Competitors
Table 100. Cambrex Corporation Product Offered
Table 101. Cambrex Corporation Mesalazine Sales (Ton), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2020E)
Table 102. Cambrex Corporation Main Business
Table 103. Cambrex Corporation Latest Developments
Table 104. Cambrex Corporation Basic Information, Company Total Revenue (in $ million), Mesalazine Manufacturing Base, Sales Area and Its Competitors
Table 105. Corden Pharma Bergamo Product Offered
Table 106. Corden Pharma Bergamo Basic Information, Company Total Revenue (in $ million), Mesalazine Manufacturing Base, Sales Area and Its Competitors
Table 107. Corden Pharma Bergamo Main Business
Table 108. Corden Pharma Bergamo Latest Developments
Table 109. Corden Pharma Bergamo Mesalazine Sales (Ton), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2020E)
Table 110. Lasa Loboratory Product Offered
Table 111. Lasa Loboratory Mesalazine Sales (Ton), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2020E)
Table 112. Lasa Loboratory Main Business
Table 113. Lasa Loboratory Latest Developments
Table 114. Lasa Loboratory Basic Information, Company Total Revenue (in $ million), Mesalazine Manufacturing Base, Sales Area and Its Competitors
Table 115. CTX Lifescience Product Offered
Table 116. CTX Lifescience Mesalazine Sales (Ton), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2020E)
Table 117. CTX Lifescience Main Business
Table 118. CTX Lifescience Latest Developments
Table 119. CTX Lifescience Basic Information, Company Total Revenue (in $ million), Mesalazine Manufacturing Base, Sales Area and Its Competitors
Table 120. Erregierre SpA Product Offered
Table 121. Erregierre SpA Mesalazine Sales (Ton), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2020E)
Table 122. Erregierre SpA Main Business
Table 123. Erregierre SpA Latest Developments
Table 124. Erregierre SpA Basic Information, Company Total Revenue (in $ million), Mesalazine Manufacturing Base, Sales Area and Its Competitors
Table 125. YC Biotech (Jiangsu) Product Offered
Table 126. YC Biotech (Jiangsu) Mesalazine Sales (Ton), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2020E)
Table 127. YC Biotech (Jiangsu) Main Business
Table 128. YC Biotech (Jiangsu) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 129. YC Biotech (Jiangsu) Latest Developments
Table 130. Xinxiang Tianfeng Fine Chemical Product Offered
Table 131. Xinxiang Tianfeng Fine Chemical Mesalazine Sales (Ton), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2020E)
Table 132. Xinxiang Tianfeng Fine Chemical Main Business
Table 133. Xinxiang Tianfeng Fine Chemical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 134. Xinxiang Tianfeng Fine Chemical Latest Developments

List of Figures

Figure 1. Picture of Mesalazine
Figure 2. Mesalazine Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Mesalazine Consumption Growth Rate 2015-2025 (Ton)
Figure 5. Global Mesalazine Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Purity = 97 %
Figure 7. Product Picture of Purity = 98 %
Figure 8. Product Picture of Purity = 99 %
Figure 9. Global Mesalazine Consumption Market Share by Type (2015-2020)
Figure 10. Global Mesalazine Value Market Share by Type (2015-2020)
Figure 11. Mesalazine Consumed in Mesalazine Tablets
Figure 12. Global Mesalazine Market: Mesalazine Tablets (2015-2020) (Ton)
Figure 13. Global Mesalazine Market: Mesalazine Tablets (2015-2020) ($ Millions)
Figure 14. Mesalazine Consumed in Mesalazine Capsules
Figure 15. Global Mesalazine Market: Mesalazine Capsules (2015-2020) (Ton)
Figure 16. Global Mesalazine Market: Mesalazine Capsules (2015-2020) ($ Millions)
Figure 17. Mesalazine Consumed in Others
Figure 18. Global Mesalazine Market: Others (2015-2020) (Ton)
Figure 19. Global Mesalazine Market: Others (2015-2020) ($ Millions)
Figure 20. Global Mesalazine Consumption Market Share by Application (2015-2020)
Figure 21. Global Mesalazine Value Market Share by Application (2015-2020)
Figure 22. Global Mesalazine Sales Market Share by Company in 2017
Figure 23. Global Mesalazine Sales Market Share by Company in 2019
Figure 24. Global Mesalazine Revenue Market Share by Company in 2017
Figure 25. Global Mesalazine Revenue Market Share by Company in 2019
Figure 26. Global Mesalazine Sale Price by Company in 2019
Figure 27. Global Mesalazine Consumption Market Share by Regions 2015-2020
Figure 28. Global Mesalazine Value Market Share by Regions 2015-2020
Figure 29. Americas Mesalazine Consumption 2015-2020 (Ton)
Figure 30. Americas Mesalazine Value 2015-2020 ($ Millions)
Figure 31. APAC Mesalazine Consumption 2015-2020 (Ton)
Figure 32. APAC Mesalazine Value 2015-2020 ($ Millions)
Figure 33. Europe Mesalazine Consumption 2015-2020 (Ton)
Figure 34. Europe Mesalazine Value 2015-2020 ($ Millions)
Figure 35. Middle East & Africa Mesalazine Consumption 2015-2020 (Ton)
Figure 36. Middle East & Africa Mesalazine Value 2015-2020 ($ Millions)
Figure 37. Americas Mesalazine Consumption Market Share by Countries in 2019
Figure 38. Americas Mesalazine Value Market Share by Countries in 2019
Figure 39. Americas Mesalazine Consumption Market Share by Type in 2019
Figure 40. Americas Mesalazine Consumption Market Share by Application in 2019
Figure 41. United States Mesalazine Consumption Growth 2015-2020 (Ton)
Figure 42. United States Mesalazine Value Growth 2015-2020 ($ Millions)
Figure 43. Canada Mesalazine Consumption Growth 2015-2020 (Ton)
Figure 44. Canada Mesalazine Value Growth 2015-2020 ($ Millions)
Figure 45. Mexico Mesalazine Consumption Growth 2015-2020 (Ton)
Figure 46. Mexico Mesalazine Value Growth 2015-2020 ($ Millions)
Figure 47. APAC Mesalazine Consumption Market Share by Countries in 2019
Figure 48. APAC Mesalazine Value Market Share by Regions in 2019
Figure 49. APAC Mesalazine Consumption Market Share by Type in 2019
Figure 50. APAC Mesalazine Consumption Market Share by Application in 2019
Figure 51. China Mesalazine Consumption Growth 2015-2020 (Ton)
Figure 52. China Mesalazine Value Growth 2015-2020 ($ Millions)
Figure 53. Japan Mesalazine Consumption Growth 2015-2020 (Ton)
Figure 54. Japan Mesalazine Value Growth 2015-2020 ($ Millions)
Figure 55. Korea Mesalazine Consumption Growth 2015-2020 (Ton)
Figure 56. Korea Mesalazine Value Growth 2015-2020 ($ Millions)
Figure 57. Southeast Asia Mesalazine Consumption Growth 2015-2020 (Ton)
Figure 58. Southeast Asia Mesalazine Value Growth 2015-2020 ($ Millions)
Figure 59. India Mesalazine Consumption Growth 2015-2020 (Ton)
Figure 60. India Mesalazine Value Growth 2015-2020 ($ Millions)
Figure 61. Australia Mesalazine Consumption Growth 2015-2020 (Ton)
Figure 62. Australia Mesalazine Value Growth 2015-2020 ($ Millions)
Figure 63. Europe Mesalazine Consumption Market Share by Countries in 2019
Figure 64. Europe Mesalazine Value Market Share by Countries in 2019
Figure 65. Europe Mesalazine Consumption Market Share by Type in 2019
Figure 66. Europe Mesalazine Consumption Market Share by Application in 2019
Figure 67. Germany Mesalazine Consumption Growth 2015-2020 (Ton)
Figure 68. Germany Mesalazine Value Growth 2015-2020 ($ Millions)
Figure 69. France Mesalazine Consumption Growth 2015-2020 (Ton)
Figure 70. France Mesalazine Value Growth 2015-2020 ($ Millions)
Figure 71. UK Mesalazine Consumption Growth 2015-2020 (Ton)
Figure 72. UK Mesalazine Value Growth 2015-2020 ($ Millions)
Figure 73. Italy Mesalazine Consumption Growth 2015-2020 (Ton)
Figure 74. Italy Mesalazine Value Growth 2015-2020 ($ Millions)
Figure 75. Russia Mesalazine Consumption Growth 2015-2020 (Ton)
Figure 76. Russia Mesalazine Value Growth 2015-2020 ($ Millions)
Figure 77. Middle East & Africa Mesalazine Consumption Market Share by Countries in 2019
Figure 78. Middle East & Africa Mesalazine Value Market Share by Countries in 2019
Figure 79. Middle East & Africa Mesalazine Consumption Market Share by Type in 2019
Figure 80. Middle East & Africa Mesalazine Consumption Market Share by Application in 2019
Figure 81. Egypt Mesalazine Consumption Growth 2015-2020 (Ton)
Figure 82. Egypt Mesalazine Value Growth 2015-2020 ($ Millions)
Figure 83. South Africa Mesalazine Consumption Growth 2015-2020 (Ton)
Figure 84. South Africa Mesalazine Value Growth 2015-2020 ($ Millions)
Figure 85. Israel Mesalazine Consumption Growth 2015-2020 (Ton)
Figure 86. Israel Mesalazine Value Growth 2015-2020 ($ Millions)
Figure 87. Turkey Mesalazine Consumption Growth 2015-2020 (Ton)
Figure 88. Turkey Mesalazine Value Growth 2015-2020 ($ Millions)
Figure 89. GCC Countries Mesalazine Consumption Growth 2015-2020 (Ton)
Figure 90. GCC Countries Mesalazine Value Growth 2015-2020 ($ Millions)
Figure 91. Global Mesalazine Consumption Growth Rate Forecast (2021-2025) (Ton)
Figure 92. Global Mesalazine Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 93. Americas Mesalazine Consumption 2021-2025 (Ton)
Figure 94. Americas Mesalazine Value 2021-2025 ($ Millions)
Figure 95. APAC Mesalazine Consumption 2021-2025 (Ton)
Figure 96. APAC Mesalazine Value 2021-2025 ($ Millions)
Figure 97. Europe Mesalazine Consumption 2021-2025 (Ton)
Figure 98. Europe Mesalazine Value 2021-2025 ($ Millions)
Figure 99. Middle East & Africa Mesalazine Consumption 2021-2025 (Ton)
Figure 100. Middle East & Africa Mesalazine Value 2021-2025 ($ Millions)
Figure 101. United States Mesalazine Consumption 2021-2025 (Ton)
Figure 102. United States Mesalazine Value 2021-2025 ($ Millions)
Figure 103. Canada Mesalazine Consumption 2021-2025 (Ton)
Figure 104. Canada Mesalazine Value 2021-2025 ($ Millions)
Figure 105. Mexico Mesalazine Consumption 2021-2025 (Ton)
Figure 106. Mexico Mesalazine Value 2021-2025 ($ Millions)
Figure 107. Brazil Mesalazine Consumption 2021-2025 (Ton)
Figure 108. Brazil Mesalazine Value 2021-2025 ($ Millions)
Figure 109. China Mesalazine Consumption 2021-2025 (Ton)
Figure 110. China Mesalazine Value 2021-2025 ($ Millions)
Figure 111. Japan Mesalazine Consumption 2021-2025 (Ton)
Figure 112. Japan Mesalazine Value 2021-2025 ($ Millions)
Figure 113. Korea Mesalazine Consumption 2021-2025 (Ton)
Figure 114. Korea Mesalazine Value 2021-2025 ($ Millions)
Figure 115. Southeast Asia Mesalazine Consumption 2021-2025 (Ton)
Figure 116. Southeast Asia Mesalazine Value 2021-2025 ($ Millions)
Figure 117. India Mesalazine Consumption 2021-2025 (Ton)
Figure 118. India Mesalazine Value 2021-2025 ($ Millions)
Figure 119. Australia Mesalazine Consumption 2021-2025 (Ton)
Figure 120. Australia Mesalazine Value 2021-2025 ($ Millions)
Figure 121. Germany Mesalazine Consumption 2021-2025 (Ton)
Figure 122. Germany Mesalazine Value 2021-2025 ($ Millions)
Figure 123. France Mesalazine Consumption 2021-2025 (Ton)
Figure 124. France Mesalazine Value 2021-2025 ($ Millions)
Figure 125. UK Mesalazine Consumption 2021-2025 (Ton)
Figure 126. UK Mesalazine Value 2021-2025 ($ Millions)
Figure 127. Italy Mesalazine Consumption 2021-2025 (Ton)
Figure 128. Italy Mesalazine Value 2021-2025 ($ Millions)
Figure 129. Russia Mesalazine Consumption 2021-2025 (Ton)
Figure 130. Russia Mesalazine Value 2021-2025 ($ Millions)
Figure 131. Spain Mesalazine Consumption 2021-2025 (Ton)
Figure 132. Spain Mesalazine Value 2021-2025 ($ Millions)
Figure 133. Egypt Mesalazine Consumption 2021-2025 (Ton)
Figure 134. Egypt Mesalazine Value 2021-2025 ($ Millions)
Figure 135. South Africa Mesalazine Consumption 2021-2025 (Ton)
Figure 136. South Africa Mesalazine Value 2021-2025 ($ Millions)
Figure 137. Israel Mesalazine Consumption 2021-2025 (Ton)
Figure 138. Israel Mesalazine Value 2021-2025 ($ Millions)
Figure 139. Turkey Mesalazine Consumption 2021-2025 (Ton)
Figure 140. Turkey Mesalazine Value 2021-2025 ($ Millions)
Figure 141. GCC Countries Mesalazine Consumption 2021-2025 (Ton)
Figure 142. GCC Countries Mesalazine Value 2021-2025 ($ Millions)
Figure 143. Syntese A/S Mesalazine Market Share (2018-2020)
Figure 144. Ishita Active Pharma Ingredients Mesalazine Market Share (2018-2020)
Figure 145. Divis Laboratories Mesalazine Market Share (2018-2020)
Figure 146. Ipca Laboratories Mesalazine Market Share (2018-2020)
Figure 147. PharmaZell Mesalazine Market Share (2018-2020)
Figure 148. Cambrex Corporation Mesalazine Market Share (2018-2020)
Figure 149. Corden Pharma Bergamo Mesalazine Market Share (2018-2020)
Figure 150. Lasa Loboratory Mesalazine Market Share (2018-2020)
Figure 151. CTX Lifescience Mesalazine Market Share (2018-2020)
Figure 152. Erregierre SpA Mesalazine Market Share (2018-2020)
Figure 153. YC Biotech (Jiangsu) Mesalazine Market Share (2018-2020)
Figure 154. Xinxiang Tianfeng Fine Chemical Mesalazine Market Share (2018-2020)
  • Global Methylprednisolone Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    Methylprednisolone is a corticosteroid medication used to reduce inflammation and suppress The immune system. It is prescribed for a wide range of medical conditions, including autoimmune disorders and inflammatory diseases. The global Methylprednisolone market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. Methylprednisolone is a widely used medication, and The market trend invol......
  • Global Ibuprofen Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 84
    Ibuprofen is an API which is used to produce ibuprofen drugs. Finished drugs ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) derivative of propionic acid used for relieving pain, helping with fever and reducing inflammation. The global Ibuprofen market was valued at US$ 93 million in 2023 and is anticipated to reach US$ 112.3 million by 2030, witnessing a CAGR of 2.7% during The forecast period 2024-2030. Market competition is intense. Xinhua Pharmaceutical, IOLCP,......
  • Global Mesalazine Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 132
    According to our LPI (LP Information) latest study, the global Mesalazine market size was valued at US$ 158.3 million in 2023. With growing demand in downstream market, the Mesalazine is forecast to a readjusted size of US$ 206 million by 2030 with a CAGR of 3.8% during review period. The research report highlights the growth potential of the global Mesalazine market. Mesalazine are expected to show stable growth in the future market. However, product differentiation, reducing costs, and......
  • Global Drugs For Sinusitis Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 109
    According to our LPI (LP Information) latest study, the global Drugs For Sinusitis market size was valued at US$ 2187.4 million in 2023. With growing demand in downstream market, the Drugs For Sinusitis is forecast to a readjusted size of US$ 2827.4 million by 2030 with a CAGR of 3.7% during review period. The research report highlights the growth potential of the global Drugs For Sinusitis market. Drugs For Sinusitis are expected to show stable growth in the future market. However, prod......
  • Global Celecoxib Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 94
    According to our LPI (LP Information) latest study, the global Celecoxib market size was valued at US$ 1243.6 million in 2023. With growing demand in downstream market, the Celecoxib is forecast to a readjusted size of US$ 2232 million by 2030 with a CAGR of 8.7% during review period. The research report highlights the growth potential of the global Celecoxib market. Celecoxib are expected to show stable growth in the future market. However, product differentiation, reducing costs, and s......
  • Global Ibuprofen Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 100
    According to our LPI (LP Information) latest study, the global Ibuprofen market size was valued at US$ 91 million in 2023. With growing demand in downstream market, the Ibuprofen is forecast to a readjusted size of US$ 110.4 million by 2030 with a CAGR of 2.8% during review period. The research report highlights the growth potential of the global Ibuprofen market. Ibuprofen are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supp......
  • Global Ketoprofen Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 94
    According to our LPI (LP Information) latest study, the global Ketoprofen market size was valued at US$ 34 million in 2023. With growing demand in downstream market, the Ketoprofen is forecast to a readjusted size of US$ 39 million by 2030 with a CAGR of 2.0% during review period. The research report highlights the growth potential of the global Ketoprofen market. Ketoprofen are expected to show stable growth in the future market. However, product differentiation, reducing costs, and sup......
  • Global Drugs for Sinusitis Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 02-Jan-2024        Price: US 3380 Onwards        Pages: 114
    Market Overview of Global Drugs for Sinusitis market: According to our latest research, the global Drugs for Sinusitis market looks promising in the next 5 years. As of 2022, the global Drugs for Sinusitis market was estimated at USD 2147.6 million, and it's anticipated to reach USD 3206.59 million in 2028, with a CAGR of 6.91% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Dru......
  • Global Ibuprofen Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 91
    According to our (Global Info Research) latest study, the global Ibuprofen market size was valued at USD 96 million in 2023 and is forecast to a readjusted size of USD 114.4 million by 2030 with a CAGR of 2.6% during review period. Ibuprofen is an API which is used to produce ibuprofen drugs. Finished drugs ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) derivative of propionic acid used for relieving pain, helping with fever and reducing inflammation. Market competitio......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs